“The successful adoption of artificial intelligence (AI) and other advanced technologies will require cooperation from multiple stakeholders, especially business leaders and the public sector.”

That’s the verdict from McKinsey & Company after it considered the potential for AI to help society as much as it does business. The Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic) at the Massachusetts Institute of Technology (MIT) is proud to be pioneering new technological advances to help all of mankind.

Launched in 2018, J-Clinic – a collaboration between MIT and Community Jameel – is a key part of the MIT Quest for Intelligence. The Clinic focuses on developing machine learning technologies to revolutionize the prevention, detection, and treatment of disease. It concentrates on creating and commercializing high-precision, affordable, and scalable machine learning technologies in areas of health care ranging from diagnostics to pharmaceuticals, with three main areas of focus:

  • Preventative medicine methods and technologies with the potential to change the course of non-infectious disease by stopping it in its tracks.
  • Cost-effective diagnostic tests that may be able to both detect and alleviate health problems.
  • Drug discovery and development to enable faster and cheaper discovery, development, and manufacture of new pharmaceuticals, particularly those targeted for individually customized therapies.

Read more about J-Clinic here. 

Read the full McKinsey & Company report here.